In March our staff based in London moved to remote working in compliance with UK government advice. Owing to our strong IT infrastructure and resolute team we were able to make the transition with minimal disruption.
We made it a priority to examine the impact of the pandemic on our research sites. Thanks to the outstanding commitment of colleagues in sites around the world, work on our ongoing programmes of research continues to the greatest extent possible.
Our operations team is now assessing how our global network can contribute to a vital new project, a clinical trial designed to clarify the role of thrombosis and anticoagulation in covid-19 disease. CYTE will partner with the Thrombosis Research Institute and a major pharma company on this study.